Adherence to complex medication regimens is critical to successful treatment of HIV infection. Unfortunately, adherence to medical regimens with conventional interventions averages 50% in chronic disease. We have observed that adherence barriers that were unrecognized by providers in the clinic setting have been detected during home visits. It is possible that recognition and interventions to resolve adherence barriers observed during home visits may improve adherence. This proposal will test the hypothesis that home-visits which identify previously unrecognized adherence barriers and provide support and education will increase medication adherence among children and youth with HIV infection and improve the patient/health care provider relationship. Specific aims of the study are: 1. Determine the impact of a series of home-visits on adherence to medication regimens for HIV infected youth and children. 1a. Adherence to medical regimens will be assessed before and after the series of home-visits using a self-report questionnaire and Microelectronic Monitoring System (MEMS) or in-home pill count. 1b. For each of these measures a percentage of adherence will be calculated and compared from a baseline to after the final home visit and after the six month follow up period. 2. Assess the changes in patient satisfaction from baseline to after the home-visits using a questionnaire completed by the patient/family. 3. Incorporate a pilot study to assess the changes in the provider's knowledge of the patient's family characteristics and home circumstances relevant to adherence following the home visits.

Condition	Treatment or Intervention
HIV Infections	Behavior: Counseling in the home

Ages Eligible for Study:  up to  24 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• HIV positive
• English speaking
• Live in Denver metro area
• Taking >=1 antiretroviral medication

Colorado
      The Children's Hospital, Denver,  Colorado,  80218,  United States

Study chairs or principal investigators

Elizabeth McFarland,  Principal Investigator

Study ID Numbers:  NCRR-M01RR00069-0622; M01RR00069
Record last reviewed:  November 2001
Last Updated:  October 13, 2004
Record first received:  November 4, 2000
ClinicalTrials.gov Identifier:  NCT00006439
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08